Early Prostate Cancer (clinical Programme)
   HOME

TheInfoList



OR:

The Early Prostate Cancer (EPC) programme was a large
clinical trial Clinical trials are prospective biomedical or behavioral research studies on human participants designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietar ...
programme of monotherapy with the nonsteroidal antiandrogen bicalutamide (Casodex) plus standard care versus standard care alone in men with
early prostate cancer The Early Prostate Cancer (EPC) programme was a large clinical trial programme of monotherapy with the nonsteroidal antiandrogen bicalutamide (Casodex) plus standard care versus standard care alone in men with early prostate cancer. It was started i ...
. It was started in August 1995, with the first analysis published in 2002 and the final follow-up published in 2010. The programme consisted of three large
randomized In common usage, randomness is the apparent or actual lack of pattern or predictability in events. A random sequence of events, symbols or steps often has no order and does not follow an intelligible pattern or combination. Individual rand ...
, double-blind, placebo-controlled trials in which a total of 8,113men with localized or locally advanced prostate cancer were treated with 150mg/day bicalutamide plus standard care ( watchful waiting,
radical prostatectomy Prostatectomy (from the Greek , "prostate" and , "excision") as a medical term refers to the surgical removal of all or part of the prostate gland. This operation is done for benign conditions that cause urinary retention, as well as for prosta ...
, or
radiation therapy Radiation therapy or radiotherapy, often abbreviated RT, RTx, or XRT, is a therapy using ionizing radiation, generally provided as part of cancer treatment to control or kill malignant cells and normally delivered by a linear accelerator. Radia ...
) (n=4052) or given
placebo A placebo ( ) is a substance or treatment which is designed to have no therapeutic value. Common placebos include inert tablets (like sugar pills), inert injections (like Saline (medicine), saline), sham surgery, and other procedures. In general ...
(standard care alone) (n=4061). It constituted the largest clinical trial of prostate cancer treatment to have ever been conducted at the time. The three trials in the EPC programme were as follows: * Trial 23 (North America; n=3292) * Trial 24 (Europe, Australia, Israel, South Africa, and Mexico; n=3603) * Trial 25 (Scandinavia; n=1218) (also known as the Scandinavian Prostate Cancer Group-6 (SPCG-6) study) Several combined follow-up papers of the EPC programme results were published, including at median 3.0years in August 2002, median 5.4years in November 2004, median 7.4years in February 2006, and median 9.7years in April 2010. The EPC programme found that bicalutamide was effective in treating locally advanced prostate cancer. Conversely, it was not effective for localized prostate cancer, where there was instead a statistically insignificant trend toward reduced
overall survival Survival rate is a part of survival analysis. It is the proportion of people in a study or treatment group still alive at a given period of time after diagnosis. It is a method of describing prognosis in certain disease conditions, and can be use ...
with bicalutamide therapy (at median 7.4years follow-up: = 1.16; 95% = 0.99–1.37; ' = 0.07). The increased
mortality Mortality is the state of being mortal, or susceptible to death; the opposite of immortality. Mortality may also refer to: * Fish mortality, a parameter used in fisheries population dynamics to account for the loss of fish in a fish stock throug ...
with bicalutamide in men with localized prostate cancer was however statistically significant at certain follow-ups in the Trial 25/SPCG-6 substudy of the EPC programme. The preceding findings led to the withdrawal of pre-existing approval of bicalutamide for localized prostate cancer in the
United Kingdom The United Kingdom of Great Britain and Northern Ireland, commonly known as the United Kingdom (UK) or Britain, is a country in Europe, off the north-western coast of the continental mainland. It comprises England, Scotland, Wales and North ...
and
Canada Canada is a country in North America. Its ten provinces and three territories extend from the Atlantic Ocean to the Pacific Ocean and northward into the Arctic Ocean, covering over , making it the world's second-largest country by tot ...
. Liver safety is an important concern with bicalutamide. In the first analysis of the EPC programme at median 3.0years of follow-up, abnormal
liver function test Liver function tests (LFTs or LFs), also referred to as a hepatic panel, are groups of blood tests that provide information about the state of a patient's liver. These tests include prothrombin time (PT/INR), activated partial thromboplastin ti ...
s had occurred in 3.4% of men treated with bicalutamide and 1.9% of men with placebo. Clinically relevant increases in aspartate transaminase (AST), alanine transaminase (ALT), and
bilirubin Bilirubin (BR) (Latin for "red bile") is a red-orange compound that occurs in the normal catabolic pathway that breaks down heme in vertebrates. This catabolism is a necessary process in the body's clearance of waste products that arise from the ...
occurred in 1.6%, 1.6%, and 0.7% with bicalutamide and in 0.5%, 0.3%, and 0.4% with placebo. However, liver changes with bicalutamide were usually transient and rarely severe. Abnormal liver function tests led to treatment withdrawal in 1.4% with bicalutamide and 0.5% with placebo. No cases of fatal hepatotoxicity occurred with bicalutamide in the SPCG-6 substudy of the EPC programme.


References

{{Reflist Clinical trials related to cancer Evidence-based medicine Prostate cancer